85 related articles for article (PubMed ID: 11772868)
1. Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload.
Sano M; Schneider MD
Circulation; 2002 Jan; 105(1):8-10. PubMed ID: 11772868
[No Abstract] [Full Text] [Related]
2. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.
Esposito G; Rapacciuolo A; Naga Prasad SV; Takaoka H; Thomas SA; Koch WJ; Rockman HA
Circulation; 2002 Jan; 105(1):85-92. PubMed ID: 11772881
[TBL] [Abstract][Full Text] [Related]
3. Genetic factors in cardiac hypertrophy.
Dorn GW; Hahn HS
Ann N Y Acad Sci; 2004 May; 1015():225-37. PubMed ID: 15201163
[TBL] [Abstract][Full Text] [Related]
4. Adenylyl cyclase: a new target for heart failure therapeutics.
Feldman AM
Circulation; 2002 Apr; 105(16):1876-8. PubMed ID: 11997269
[No Abstract] [Full Text] [Related]
5. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.
Wettschureck N; Rütten H; Zywietz A; Gehring D; Wilkie TM; Chen J; Chien KR; Offermanns S
Nat Med; 2001 Nov; 7(11):1236-40. PubMed ID: 11689889
[TBL] [Abstract][Full Text] [Related]
6. What is the role of beta-adrenergic signaling in heart failure?
Lohse MJ; Engelhardt S; Eschenhagen T
Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
[TBL] [Abstract][Full Text] [Related]
8. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Zheng M; Han QD; Xiao RP
Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
[TBL] [Abstract][Full Text] [Related]
9. Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature.
Keys JR; Greene EA; Koch WJ; Eckhart AD
Hypertension; 2002 Nov; 40(5):660-6. PubMed ID: 12411459
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.
Hata JA; Koch WJ
Mol Interv; 2003 Aug; 3(5):264-72. PubMed ID: 14993440
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenergic receptor-mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3-kinase dependent pathway refractory to the antiproliferative action of cyclic AMP.
Colombo F; Gosselin H; El-Helou V; Calderone A
J Cell Physiol; 2003 May; 195(2):322-30. PubMed ID: 12652658
[TBL] [Abstract][Full Text] [Related]
13. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
[TBL] [Abstract][Full Text] [Related]
15. G protein-coupled receptor kinase 2--a feedback regulator of Gq pathway signalling.
Theilade J; Haunsø S; Sheikh SP
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):139-51. PubMed ID: 12476795
[TBL] [Abstract][Full Text] [Related]
16. Loss of association between activated Galpha q and Gbetagamma disrupts receptor-dependent and receptor-independent signaling.
Evanko DS; Thiyagarajan MM; Takida S; Wedegaertner PB
Cell Signal; 2005 Oct; 17(10):1218-28. PubMed ID: 16038796
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
[TBL] [Abstract][Full Text] [Related]
18. Dual regulation of heat-activated K+ channel in rat DRG neurons via alpha(1) and beta adrenergic receptors.
Yamamoto S; Kanno T; Yamada K; Yasuda Y; Nishizaki T
Life Sci; 2009 Jul; 85(3-4):167-71. PubMed ID: 19470391
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors.
Fan J; Malik AB
Nat Med; 2003 Mar; 9(3):315-21. PubMed ID: 12592402
[TBL] [Abstract][Full Text] [Related]
20. Characterization of GRK2 RH domain-dependent regulation of GPCR coupling to heterotrimeric G proteins.
Sterne-Marr R; Dhami GK; Tesmer JJ; Ferguson SS
Methods Enzymol; 2004; 390():310-36. PubMed ID: 15488186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
